CLINICAL_TRIALS
trial_result
· 2023-08-31
Clinical Trial Update: The Efficacy and Safety of KN046 Combined With Axitinib [Phase 2, Phase 3]
Summary
Clinical trial update on KN046 with axitinib for non-small cell lung cancer (NSCLC) across Phase 2 and Phase 3, with status currently UNKNOWN.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: NSCLC | Phase 2, Phase 3 | Status: UNKNOWN